Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G K Rivera

Showing results (41-50 of 117) with videos related to

Pageof 12
Sort By:
Leukemia|May 1, 1994
Molecular evidence for minimal residual bone marrow disease in children with 'isolated' extra-medullary relapse of T-cell acute lymphoblastic leukemiaG A Neale, C H Pui, H H Mahmoud, et al.
Blood|November 1, 1988
Cytogenetics of childhood T-cell leukemiaS C Raimondi, F G Behm, P K Roberson, et al.
Journal of Pediatric Hematology/Oncology|October 19, 1999
Bacillus cereus causing fulminant sepsis and hemolysis in two patients with acute leukemiaM K Arnaout, R F Tamburro, S M Bodner, et al.
Leukemia|March 1, 1992
Trisomy 21 as the sole acquired chromosomal abnormality in children with acute lymphoblastic leukemiaS C Raimondi, C H Pui, D Head, et al.
Medical and Pediatric Oncology|January 1, 1991
Concept of maximum tolerated systemic exposure and its application to phase I-II studies of anticancer drugsW E Evans, J H Rodman, M V Relling, et al.
Blood|August 1, 1993
Clinical significance of CD34 expression in childhood acute lymphoblastic leukemiaC H Pui, M L Hancock, D R Head, et al.
Cancer|February 15, 1991
Hypersensitivity reactions to epipodophyllotoxins in children with acute lymphoblastic leukemiaS J Kellie, W M Crist, C H Pui, et al.
Blood|August 15, 1995
Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemiaA Gajjar, R Ribeiro, M L Hancock, et al.
Lancet (London, England)|February 5, 1994
Intensive chemotherapy for Philadelphia-chromosome-positive acute lymphoblastic leukaemiaW M Roberts, G K Rivera, S C Raimondi, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1992
Differences in teniposide disposition and pharmacodynamics in patients with newly diagnosed and relapsed acute lymphocytic leukemiaW E Evans, J H Rodman, M V Relling, et al.
Pageof 12

Showing results (41-50 of 117) with videos related to

Sort By:
Pageof 12
Leukemia|May 1, 1994
Molecular evidence for minimal residual bone marrow disease in children with 'isolated' extra-medullary relapse of T-cell acute lymphoblastic leukemiaG A Neale, C H Pui, H H Mahmoud, et al.
Blood|November 1, 1988
Cytogenetics of childhood T-cell leukemiaS C Raimondi, F G Behm, P K Roberson, et al.
Journal of Pediatric Hematology/Oncology|October 19, 1999
Bacillus cereus causing fulminant sepsis and hemolysis in two patients with acute leukemiaM K Arnaout, R F Tamburro, S M Bodner, et al.
Leukemia|March 1, 1992
Trisomy 21 as the sole acquired chromosomal abnormality in children with acute lymphoblastic leukemiaS C Raimondi, C H Pui, D Head, et al.
Medical and Pediatric Oncology|January 1, 1991
Concept of maximum tolerated systemic exposure and its application to phase I-II studies of anticancer drugsW E Evans, J H Rodman, M V Relling, et al.
Blood|August 1, 1993
Clinical significance of CD34 expression in childhood acute lymphoblastic leukemiaC H Pui, M L Hancock, D R Head, et al.
Cancer|February 15, 1991
Hypersensitivity reactions to epipodophyllotoxins in children with acute lymphoblastic leukemiaS J Kellie, W M Crist, C H Pui, et al.
Blood|August 15, 1995
Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemiaA Gajjar, R Ribeiro, M L Hancock, et al.
Lancet (London, England)|February 5, 1994
Intensive chemotherapy for Philadelphia-chromosome-positive acute lymphoblastic leukaemiaW M Roberts, G K Rivera, S C Raimondi, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1992
Differences in teniposide disposition and pharmacodynamics in patients with newly diagnosed and relapsed acute lymphocytic leukemiaW E Evans, J H Rodman, M V Relling, et al.
Pageof 12